Jump Capital

Balto develops AI-powered real-time guidance and conversation analytics for contact centers. Its SaaS platform listens to live calls and provides instant prompts, tips, and corrective suggestions to sales and service agents to identify pain signals, handle objections, and balance talk time, with dashboards for managers to monitor performance and compliance. The solution aims to prevent missed opportunities and costly compliance mistakes by guiding agents during calls and flagging non-compliant language. The platform serves sales, customer service, accounts receivable, and compliance quality use cases. Balto was founded in 2017 and is based in Saint Louis, Missouri.

Balto develops AI-powered real-time guidance and conversation analytics for contact centers. Its SaaS platform listens to live calls and provides instant prompts, tips, and corrective suggestions to sales and service agents to identify pain signals, handle objections, and balance talk time, with dashboards for managers to monitor performance and compliance. The solution aims to prevent missed opportunities and costly compliance mistakes by guiding agents during calls and flagging non-compliant language. The platform serves sales, customer service, accounts receivable, and compliance quality use cases. Balto was founded in 2017 and is based in Saint Louis, Missouri.

Balto develops AI-powered real-time guidance and conversation analytics for contact centers. Its SaaS platform listens to live calls and provides instant prompts, tips, and corrective suggestions to sales and service agents to identify pain signals, handle objections, and balance talk time, with dashboards for managers to monitor performance and compliance. The solution aims to prevent missed opportunities and costly compliance mistakes by guiding agents during calls and flagging non-compliant language. The platform serves sales, customer service, accounts receivable, and compliance quality use cases. Balto was founded in 2017 and is based in Saint Louis, Missouri.

MediBeacon is an optical diagnostics company developing real-time organ function monitoring solutions. Its portfolio focuses on fluorescent tracer-agent systems that enable continuous assessment of kidney function, including the NIC-Kidney device for monitoring glomerular filtration rate in preclinical settings and a renal function system that pairs an optical skin sensor with a proprietary light-activated agent to provide continuous real-time kidney monitoring in clinical environments. The company also maintains a pipeline of light-activated agents for physiological monitoring, surgical guidance and imaging. By commercializing biocompatible optical agents, MediBeacon aims to support critical care and surgical decision-making, enhancing dosing accuracy and patient outcomes in ICUs and operating suites. The technology supports monitoring of kidney and other vital organ functions, helping clinicians intervene in a timely manner.